March trading has started with a bang. The Dow closed down 400 points today after two big events. President Trump announced tariffs on steel and aluminum and the new Fed Chair, Jerome Powell, testified in front of the Senate Finance Committee.
Chad Leat is a former Citigroup and JPMorgan Chase executive. Leat joins Cheddar to break down the market movement and recent volatility.
When asked about President Trump's announcement about tariffs, Leat says good and fair trade traffics make for good politics, but willy-nilly tariffs are bad policy.
When it comes to the current state of the market, Leat says everyone has the same worry in their mind, inflation.
Leat says the highs the market saw in January were not sustainable. He explains the daily ups and downs of the market tend to freak people out, especially when they go down. But Leat encourages investors to try to look at the overall market and understand the full market. Leat says it is still a good time to be in the market, longterm.
It might not be what investors want to hear… but bringing down inflation could mean interest rates stay higher for (even) longer. But it's not all downside.
President Joe Biden and Chinese President Xi Jinping have discussed Taiwan, artificial intelligence and security issues in a call meant to demonstrate a return to regular leader-to-leader dialogue between the two powers.
April is Earth month, and while the green revolution might feel far away, the founder of climate VC Siam Capital says it’s on it’s way, and, even better: it won't cost you more.
From snow in April to heatwaves in December, it’s hard to plan a trip in a climate change world. Startup Sensible Weather thinks weather-based travel reimbursements are the solution.
Between corporate debt and the widening gap between ‘the haves and the have nots,’ there are reasons to be cautious about the economy, even with interest rate cuts on their way.
If the A.I. hype hasn’t given you enough of a reason to be excited (and a little terrified), the CEO of Zapata AI says the next frontier is designing bridges or creating pharmaceutical drugs.
